InsiderBoltOpen live tracker
Home › Stocks › ROIV insider trading

ROIV insider trading — Roivant Sciences Ltd.

Over the last 90 days, insiders at Roivant Sciences Ltd. (ROIV) made 0 open-market purchases worth $0 and 6 open-market sales worth $36.52M, making them net sellers by $36.52M. The largest sale was by Sukhatme Mayukh (President & CIO), who sold 284,707 shares for $10.32M on Aug 17, 2026.

Updated Oct 16, 2026.

Insider buying · 90d
$0
Insider selling · 90d
$36.52M
Net · 90d
−$36.52M
Last 30 days
0B / 0S

Scan ROIV live in the tracker

Recent ROIV insider transactions

Every Form 4 filed by Roivant Sciences Ltd. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.

Trade dateInsiderRoleTypeOwnershipSharesPriceValueFiling
Oct 1, 2026Epperly Melissa B,DirectorM · Option exercise · 10b5-1Direct17,750$4.46$79KForm 4
Oct 1, 2026Epperly Melissa B,DirectorS · Sale · 10b5-1Direct17,750$36.10$641KForm 4
Sep 30, 2026Torti FrankPresident and Vant ChairF · Tax withholdingDirect40,309$36.57$1.47MForm 4
Sep 30, 2026Gline MatthewCEOF · Tax withholdingDirect76,171$36.57$2.79MForm 4
Sep 30, 2026Sukhatme MayukhPresident & CIOF · Tax withholdingDirect46,879$36.57$1.71MForm 4
Sep 30, 2026Venker EricPresident & Immunovant CEOM · Option exercise · 10b5-1Direct200,000$3.85$770KForm 4
Sep 30, 2026Venker EricPresident & Immunovant CEOS · Sale · 10b5-1Direct200,000$36.62$7.32MForm 4
Sep 20, 2026Humes JenniferChief Accounting OfficerF · Tax withholdingDirect3,880$39.77$154KForm 4
Sep 20, 2026Pulik RichardCFOF · Tax withholdingDirect2,129$39.77$85KForm 4
Sep 16, 2026Manchester Keith SDirectorA · Grant/awardDirect5,054——Form 4
Sep 16, 2026Gold Daniel AllenDirectorA · Grant/awardDirect5,054——Form 4
Sep 16, 2026Oren IlanDirectorA · Grant/awardDirect5,054——Form 4
Sep 16, 2026Momtazee James CDirectorA · Grant/awardDirect5,054——Form 4
Sep 16, 2026Fitzgerald MeghanDirectorA · Grant/awardDirect5,054——Form 4
Sep 16, 2026Epperly Melissa B,DirectorA · Grant/awardDirect5,054——Form 4
Sep 15, 2026Epperly Melissa B,DirectorS · Sale · 10b5-1Direct4,938$39.74$196KForm 4
Sep 15, 2026Fitzgerald MeghanDirectorS · Sale · 10b5-1Direct5,112$39.74$203KForm 4
Sep 10, 2026Gold Daniel AllenDirectorF · Tax withholdingDirect5,133$40.94$210KForm 4
Sep 10, 2026Oren IlanDirectorF · Tax withholdingDirect2,378$40.94$97KForm 4
Sep 10, 2026Epperly Melissa B,DirectorF · Tax withholdingDirect2,179$40.94$89KForm 4
Sep 10, 2026Fitzgerald MeghanDirectorF · Tax withholdingDirect1,743$40.94$71KForm 4
Sep 10, 2026Momtazee James CDirectorF · Tax withholdingDirect2,905$40.94$119KForm 4
Sep 8, 2026Fitzgerald MeghanDirectorM · Option exercise · 10b5-1Direct20,000$8.80$176KForm 4
Sep 8, 2026Fitzgerald MeghanDirectorS · Sale · 10b5-1Direct20,000$39.90$798KForm 4
Aug 28, 2026Venker EricPresident & Immunovant CEOM · Option exercise · 10b5-1Direct200,000$3.85$770KForm 4
Aug 28, 2026Venker EricPresident & Immunovant CEOS · Sale · 10b5-1Direct200,000$35.77$7.15MForm 4
Aug 20, 2026Venker EricPresident & Immunovant CEOF · Tax withholdingDirect13,909$36.84$512KForm 4
Aug 20, 2026Pulik RichardCFOF · Tax withholdingDirect5,749$36.84$212KForm 4
Aug 21, 2026Sukhatme MayukhPresident & CIOM · Option exerciseDirect144,756$3.85$557KForm 4
Aug 21, 2026Sukhatme MayukhPresident & CIOS · SaleDirect144,756$36.48$5.28MForm 4
Aug 20, 2026Sukhatme MayukhPresident & CIOM · Option exerciseDirect17,519$3.85$67KForm 4
Aug 20, 2026Sukhatme MayukhPresident & CIOS · SaleDirect17,519$37.30$653KForm 4
Aug 19, 2026Sukhatme MayukhPresident & CIOM · Option exerciseDirect172,899$3.85$666KForm 4
Aug 19, 2026Sukhatme MayukhPresident & CIOS · SaleDirect172,899$37.17$6.43MForm 4
Aug 18, 2026Sukhatme MayukhPresident & CIOM · Option exerciseDirect136,942$3.85$527KForm 4
Aug 18, 2026Sukhatme MayukhPresident & CIOS · SaleDirect136,942$36.73$5.03MForm 4
Aug 17, 2026Sukhatme MayukhPresident & CIOM · Option exerciseDirect284,707$3.85$1.10MForm 4
Aug 17, 2026Sukhatme MayukhPresident & CIOS · SaleDirect284,707$36.25$10.32MForm 4
Aug 14, 2026Sukhatme MayukhPresident & CIOM · Option exerciseDirect243,177$3.85$936KForm 4
Aug 14, 2026Sukhatme MayukhPresident & CIOS · SaleDirect243,177$36.23$8.81MForm 4
Jul 27, 2026Venker EricPresident & Immunovant CEOM · Option exercise · 10b5-1Direct200,000$3.85$770KForm 4
Jul 27, 2026Venker EricPresident & Immunovant CEOS · Sale · 10b5-1Direct200,000$34.95$6.99MForm 4
Jul 17, 2026Momtazee James CDirectorA · Grant/awardDirect405——Form 4
Jul 17, 2026Oren IlanDirectorA · Grant/awardDirect775——Form 4
Jul 17, 2026Epperly Melissa B,DirectorA · Grant/awardDirect543——Form 4

ROIV insider trading FAQ

Are insiders buying ROIV stock?

Not on the open market. In the last 90 days, Roivant Sciences Ltd. insiders made no open-market purchases, and 6 open-market sales totaling $36.52M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).

Who are the insiders trading ROIV?

Recent sellers: Sukhatme Mayukh.

Where does ROIV insider trading data come from?

Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.

More stocks with insider activity

NYAXNayax Ltd.KBDCKayne Anderson BDC, Inc.GMEGameStop Corp.GSATGlobalstar, Inc.BCBPBCB Bancorp IncFULFuller H B CoBWMXBetterware de Mexico, S.A.P.I. de C.VFGBIFirst Guaranty Bancshares, Inc.BORRBorr Drilling LtdAGMBAgomAb Therapeutics NVHHHHoward Hughes Holdings Inc.CVCapsoVision, Inc

Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.